217 related articles for article (PubMed ID: 27665844)
21. The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group.
Iriyama N; Ohashi K; Hashino S; Kimura S; Nakaseko C; Takano H; Hino M; Uchiyama M; Morita S; Sakamoto J; Sakamaki H; Inokuchi K
Intern Med; 2018 Jan; 57(1):17-23. PubMed ID: 29033428
[TBL] [Abstract][Full Text] [Related]
22. Dasatinib, large granular lymphocytosis, and pleural effusion: useful or adverse effect?
Paydas S
Crit Rev Oncol Hematol; 2014 Feb; 89(2):242-7. PubMed ID: 24210599
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion.
Nagata Y; Ohashi K; Fukuda S; Kamata N; Akiyama H; Sakamaki H
Int J Hematol; 2010 Jun; 91(5):799-807. PubMed ID: 20405252
[TBL] [Abstract][Full Text] [Related]
24. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
25. [A case report of refractory pleural effusion associated with dasatinib in the treatment of chronic myeloied leukemia].
Zhang ZC; Qaio JH; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):401-6. PubMed ID: 25948193
[TBL] [Abstract][Full Text] [Related]
26. [Dasatinib-related pulmonary adverse events in patients with chronic myeloid leukemia].
Yang S; Qin YZ; Lai YY; Shi HX; Hou Y; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1013-1019. PubMed ID: 33445849
[No Abstract] [Full Text] [Related]
27. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
Kaiafa G; Kakaletsis N; Savopoulos C; Perifanis V; Giannouli A; Papadopoulos N; Zisekas S; Hatzitolios AI
J Clin Pharm Ther; 2014 Feb; 39(1):102-5. PubMed ID: 24188312
[TBL] [Abstract][Full Text] [Related]
28. Large granular lymphocytosis during dasatinib therapy.
Qiu ZY; Xu W; Li JY
Cancer Biol Ther; 2014 Mar; 15(3):247-55. PubMed ID: 24352048
[TBL] [Abstract][Full Text] [Related]
29. Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib.
Maral S; Bakanay SM; Kucuksahin O; Dilek I
J Oncol Pharm Pract; 2020 Apr; 26(3):738-741. PubMed ID: 31359838
[TBL] [Abstract][Full Text] [Related]
30. Attenuated Dose Dasatinib in Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase Patients in India.
Ahmed R; Singh R; Kapoor J; Chandra Patra P; Agrawal N; Bhurani D; Halder R
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e71-e77. PubMed ID: 36566108
[TBL] [Abstract][Full Text] [Related]
31. Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.
Nakamae H; Fujisawa S; Ogura M; Uchida T; Onishi Y; Taniwaki M; Utsunomiya A; Matsue K; Takamatsu Y; Usuki K; Tanimoto M; Ishida Y; Ohashi K; Li L; Miyoshi M
Int J Hematol; 2017 Jun; 105(6):792-804. PubMed ID: 28341918
[TBL] [Abstract][Full Text] [Related]
32. Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
Latagliata R; Breccia M; Fava C; Stagno F; Tiribelli M; Luciano L; Gozzini A; Gugliotta G; Annunziata M; Cavazzini F; Ferrero D; Musto P; Capodanno I; Iurlo A; Visani G; Crugnola M; Calistri E; Castagnetti F; Vigneri P; Alimena G
Hematol Oncol; 2013 Jun; 31(2):103-9. PubMed ID: 22815278
[TBL] [Abstract][Full Text] [Related]
33. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
34. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
[TBL] [Abstract][Full Text] [Related]
35. An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia after Experiencing Pleural Effusion during Dasatinib Therapy.
McBride A; Brokars J; Reddy SR; Chang E; Tarbox MH; LeBlanc TW
Acta Haematol; 2023; 146(4):259-266. PubMed ID: 37037194
[TBL] [Abstract][Full Text] [Related]
36. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
Yang L; Lu N; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study.
Kim DW; Saussele S; Williams LA; Mohamed H; Rong Y; Zyczynski T; Pinilla-Ibarz J; Abruzzese E
Ann Hematol; 2018 Aug; 97(8):1357-1367. PubMed ID: 29556695
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia.
Ishida Y; Murai K; Yamaguchi K; Miyagishima T; Shindo M; Ogawa K; Nagashima T; Sato S; Watanabe R; Yamamoto S; Hirose T; Saitou S; Yonezumi M; Kondo T; Kato Y; Mochizuki N; Ohno K; Kishino S; Kubo K; Oyake T; Ito S;
Eur J Clin Pharmacol; 2016 Feb; 72(2):185-93. PubMed ID: 26507546
[TBL] [Abstract][Full Text] [Related]
39. Dasatinib: A Review in Pediatric Chronic Myeloid Leukemia.
McCafferty EH; Dhillon S; Deeks ED
Paediatr Drugs; 2018 Dec; 20(6):593-600. PubMed ID: 30465234
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia.
Kojima M; Nakamura N; Amaki J; Numata H; Miyaoka M; Motoori T; Matsumoto K; Ando K
J Clin Exp Hematop; 2017; 57(2):69-73. PubMed ID: 29021516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
